Select Medical Holdings Corporation (NYSE:SEM) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Select Medical Holdings Corporation (NYSE:SEM) has been given an average recommendation of “Moderate Buy” by the six research firms that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and four have given a buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $17.80.

SEM has been the topic of a number of recent research reports. Benchmark reaffirmed a “buy” rating on shares of Select Medical in a research report on Monday, October 27th. Mizuho set a $17.00 price target on shares of Select Medical in a research report on Monday, November 3rd. Weiss Ratings reissued a “sell (d+)” rating on shares of Select Medical in a research report on Wednesday. Wall Street Zen raised Select Medical from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Finally, Royal Bank Of Canada boosted their price target on Select Medical from $16.00 to $20.00 and gave the company an “outperform” rating in a research note on Wednesday, October 8th.

Select Medical Price Performance

Shares of Select Medical stock opened at $15.25 on Friday. Select Medical has a 52 week low of $11.65 and a 52 week high of $20.83. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.87. The stock has a market cap of $1.89 billion, a PE ratio of 17.73, a price-to-earnings-growth ratio of 0.54 and a beta of 1.26. The company’s 50-day moving average price is $14.87 and its two-hundred day moving average price is $13.88.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, October 30th. The health services provider reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.05. Select Medical had a net margin of 2.05% and a return on equity of 7.41%. The company had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter in the previous year, the company posted $0.43 EPS. The business’s revenue was up 7.2% compared to the same quarter last year. Select Medical has set its FY 2025 guidance at 1.140-1.240 EPS. As a group, sell-side analysts anticipate that Select Medical will post 1.17 EPS for the current fiscal year.

Select Medical Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 25th. Stockholders of record on Wednesday, November 12th were issued a dividend of $0.0625 per share. The ex-dividend date was Wednesday, November 12th. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.6%. Select Medical’s dividend payout ratio (DPR) is currently 29.07%.

Hedge Funds Weigh In On Select Medical

Several institutional investors have recently bought and sold shares of the stock. Quantbot Technologies LP acquired a new stake in shares of Select Medical in the third quarter worth about $27,000. MAI Capital Management lifted its holdings in Select Medical by 48,000.0% in the 2nd quarter. MAI Capital Management now owns 2,405 shares of the health services provider’s stock worth $37,000 after purchasing an additional 2,400 shares during the last quarter. Cornerstone Planning Group LLC boosted its position in Select Medical by 6,868.4% during the third quarter. Cornerstone Planning Group LLC now owns 3,972 shares of the health services provider’s stock worth $51,000 after purchasing an additional 3,915 shares during the period. GAMMA Investing LLC grew its holdings in Select Medical by 147.9% during the fourth quarter. GAMMA Investing LLC now owns 4,713 shares of the health services provider’s stock valued at $70,000 after purchasing an additional 2,812 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB raised its position in shares of Select Medical by 20.9% in the third quarter. Wilmington Savings Fund Society FSB now owns 5,784 shares of the health services provider’s stock valued at $74,000 after purchasing an additional 999 shares during the period. 89.48% of the stock is currently owned by institutional investors.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.